首页 › 基金 › Blue Owl Capital Holdings LP › AKTS
Blue Owl Capital Holdings LP 对 AKTS 的持仓历史
AKTIS ONCOLOGY INC · 医疗保健
Blue Owl Capital Holdings LP 在 Q3 2026 的 13F 申报中披露持有 AKTS(AKTIS ONCOLOGY INC)3,343,827 股,市值约 US$65.1M,约占其申报组合的 12.24%,在其申报持仓中市值排名第 2 位。 Blue Owl Capital Holdings LP 最近 3 个申报季度中有 3 个季度披露了 AKTS 持仓,最早可追溯至 Q1 2026。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Blue Owl Capital Holdings LP 对 AKTS 的持仓演变
Blue Owl Capital Holdings LP 于 Q1 2026 首次披露 AKTS 持仓:3,161,348 股(约 US$56.6M)。 该持仓在 Q2 2026 达到峰值 3,070,219 股,市值约 US$99.0M。 在 3 次申报中,Blue Owl Capital Holdings LP 1 次增持、1 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 3,343,827 股、市值约 US$65.1M,环比增持 273,608 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2026 | 3.16M | $56.56M | 新进 |
| Q2 2026 | 3.07M | $98.95M | 减持 |
| Q3 2026 | 3.34M | $65.10M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 AKTS 与 13F 数据
AKTS(AKTIS ONCOLOGY INC)属于医疗保健行业。我们追踪的基金中还有 123 只申报持有 AKTS,申报仓位最大的包括:MPM BioImpact LLC (US$155.9M), EcoR1 Capital, LLC (US$155.5M), RTW INVESTMENTS, LP (US$51.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 AKTS 的基金
- MPM BioImpact LLC 4.84M 股 · $155.86M · Q2 2026
- EcoR1 Capital, LLC 4.82M 股 · $155.49M · Q2 2026
- RTW INVESTMENTS, LP 1.59M 股 · $51.31M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 1.31M 股 · $42.36M · Q2 2026
- BAKER BROS. ADVISORS LP 996.35K 股 · $32.11M · Q2 2026
- Octagon Capital Advisors LP 960.85K 股 · $30.97M · Q2 2026
- Merck & Co., Inc. 952.84K 股 · $30.71M · Q2 2026
- TCG Crossover Management, LLC 696.56K 股 · $22.45M · Q2 2026
- Avidity Partners Management LP 484.20K 股 · $15.61M · Q2 2026
- a16z Capital Management, L.L.C. 415.00K 股 · $13.38M · Q2 2026
更多关于 Blue Owl Capital Holdings LP
常见问题
How long has Blue Owl Capital Holdings LP held AKTS?
Blue Owl Capital Holdings LP has disclosed AKTS holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Blue Owl Capital Holdings LP's current position in AKTS?
As of Q3 2026, Blue Owl Capital Holdings LP holds 3.34M shares of AKTS (AKTIS ONCOLOGY INC), valued at $65.10M, representing 12.24% of its reported portfolio and ranking #2.
Has Blue Owl Capital Holdings LP been buying or selling AKTS?
In the latest 13F filing (Q3 2026), Blue Owl Capital Holdings LP increased its position in AKTS. The position peaked in Q2 2026 at 3.07M shares.
Which other funds hold AKTS?
Other major institutional holders of AKTS include MPM BioImpact LLC, EcoR1 Capital, LLC, RTW INVESTMENTS, LP, among 123 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.